Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Lieberman · SciRah

Researcher profile · Semantic Scholar

R. Lieberman

Share profile

R. Lieberman — researcher profile on SciRah

h-index: 29
Works: 93
Citations: 3,072

Most-cited papers

Progress in cancer chemoprevention: development of diet-derived chemopreventive agents.
G. Kelloff, J. Crowell, V. Steele, R. Lubet +9 more
2000Journal of NutriLife437 citations Open access
Semantic Scholar
Consensus Document: Therapeutic Monitoring of Tacrolimus (FK‐506)
W. Jusko, A. Thomson, J. Fung, P. Mcmaster +10 more
1995273 citations
Semantic Scholar
Progress in Cancer Chemoprevention
G. Kelloff, James A. Crowell, Vernon E. Steele, R. Lubet +9 more
1999Annals of the New York Academy of Sciences158 citations
Semantic Scholar
Chemoprevention of Prostate Cancer: Concepts and Strategies
G. Kelloff, R. Lieberman, V. Steele, C. Boone +5 more
1999European Urology139 citations
Semantic Scholar
Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.
C. Takimoto, Kira Glover, Xiao-Ke Huang, S. Hayes +11 more
2003Cancer Epidemiology, Biomarkers and Prevention134 citations
Semantic Scholar
Mycophenolate Mofetil: A Report of the Consensus Panel
L. Shaw, H. Sollinger, P. Halloran, R. Morris +8 more
1995Therapeutic Drug Monitoring112 citations
Semantic Scholar
Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer.
P. Arlen, J. Gulley, N. Todd, R. Lieberman +9 more
2005Journal of Urology108 citations Open access
Semantic Scholar
Lycopene in Cancer Prevention and Treatment
S. Seren, R. Lieberman, U. Bayraktar, E. Heath +3 more
2008American Journal of Therapeutics100 citations Open access
Semantic Scholar
Prevention of bladder cancer: a review.
J. Leppert, O. Shvarts, K. Kawaoka, R. Lieberman +2 more
2006European Urology90 citations Open access
Semantic Scholar
The Effect of Difluoromethylornithine on Decreasing Prostate Size and Polyamines in Men: Results of a Year-Long Phase IIb Randomized Placebo-Controlled Chemoprevention Trial
A. Simoneau, E. Gerner, R. Nagle, A. Ziogas +7 more
2008Cancer Epidemiology, Biomarkers and Prevention86 citations Open access
Semantic Scholar
Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients.
W. Dahut, N. Harold, Chris H. M. Takimoto, Carmen J. Allegra +10 more
1996Journal of Clinical Oncology73 citations
Semantic Scholar
Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer.
G. Kelloff, R. Lieberman, V. Steele, C. Boone +6 more
2001Urology67 citations
Semantic Scholar
Disposition of Phenylbutyrate and its Metabolites, Phenylacetate and Phenylacetylglutamine
S. Piscitelli, A. Thibault, W. Figg, A. Tompkins +4 more
1995Journal of clinical pharmacology67 citations
Semantic Scholar
Pharmacokinetics of amifostine: effects of dose and method of administration.
L. Shaw, H. Bonner, Lynn M. Schuchter, J. Schiller +1 more
1999Seminars in Oncology65 citations
Semantic Scholar
Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancer.
R. Lieberman
2004American Journal of Therapeutics55 citations
Semantic Scholar
Chemoprevention of Prostate Cancer: Current Status and Future Directions
R. Lieberman
2004Cancer Metastasis Review50 citations
Semantic Scholar
Pharmacokinetic profile of amifostine.
L. Shaw, H. Bonner, R. Lieberman
1996Seminars in Oncology46 citations
Semantic Scholar
Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients.
Chris H. M. Takimoto, W. Dahut, M. Marino, Hiroshi Nakashima +10 more
1997Journal of Clinical Oncology45 citations
Semantic Scholar
Design and Progress of a Trial of Selenium to Prevent Prostate Cancer among Men with High-Grade Prostatic Intraepithelial Neoplasia
J. Marshall, W. Sakr, D. Wood, D. Berry +11 more
2006Cancer Epidemiology, Biomarkers and Prevention44 citations Open access
Semantic Scholar
Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-β-1-integrin complex formation
Yueqin Liu, E. Kyle, R. Lieberman, J. Crowell +2 more
2004Clinical and Experimental Metastasis43 citations
Semantic Scholar
Adaptive control with feedback strategies for suramin dosing
Michael R. Cooper, R. Lieberman, R. L. la Rocca, Paige R. Gernt +6 more
1992Clinical pharmacology and therapy43 citations
Semantic Scholar
Induction of major histocompatibility class I antigens by interferons in undifferentiated F9 cells
Y. Wan, Bonnie M. Orrison, R. Lieberman, P. Lazarovici +1 more
1987Journal of Cellular Physiology43 citations
Semantic Scholar
Evaluation of Biomarker Modulation by Fenretinide in Prostate Cancer Patients
D. Urban, R. Myers, U. Manne, Heidi L. Weiss +7 more
1999European Urology38 citations
Semantic Scholar
Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.
R. Lieberman
2001Urology35 citations
Semantic Scholar
Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells
Y.-Q. Liu, E. Kyle, S. Patel, F. Housseau +5 more
2001Prostate Cancer and Prostatic Diseases32 citations
Semantic Scholar
Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio.
H. Parnes, M. House, J. Kagan, David J Kausal +1 more
2004Journal of Urology31 citations
Semantic Scholar
Strategies for chemoprevention of prostate cancer
G. Kelloff, R. Lieberman, M. K. Brawer, E. Crawford +2 more
1999Prostate Cancer and Prostatic Diseases31 citations Open access
Semantic Scholar
Principles of drug development in transplantation and autoimmunity
R. Lieberman, A. Mukherjee
199531 citations
Semantic Scholar
Levamisole-mediated restoration of cellular immunity in peripheral blood lymphocytes of patients with immunodeficiency diseases.
R. Lieberman, Mae Hsu
1976Clinical Immunology and Immunopathology30 citations
Semantic Scholar
Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development.
R. Lieberman
2001Urology28 citations
Semantic Scholar
Development of new cancer chemoprevention agents: role of pharmacokinetic/pharmacodynamic and intermediate endpoint biomarker monitoring.
R. Lieberman, J. Crowell, E. Hawk, C. Boone +2 more
1998Clinical Chemistry28 citations
Semantic Scholar
Changes in Serum Proteomic Patterns by Presurgical α-Tocopherol and l-Selenomethionine Supplementation in Prostate Cancer
Jeri Kim, P. Sun, Ying W. Lam, P. Troncoso +10 more
2005Cancer Epidemiology, Biomarkers and Prevention27 citations Open access
Semantic Scholar
Progress in prostate cancer chemoprevention: modulators of promotion and progression.
R. Lieberman, Carlos E. Bermejo, Hideyuki Akaza, Peter Greenwald +2 more
2001Urology26 citations
Semantic Scholar
Randomization, Pk-Controlled Dosing, and Titration: An Integrated Approach for Designing Clinical Trials
L. Sanathanan, C. Peck, R. Temple, R. Lieberman +1 more
199125 citations
Semantic Scholar
Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
R. Lieberman, W. Nelson, Wael A. Sakr, F. Meyskens +5 more
2001Urology24 citations Open access
Semantic Scholar
Role of pharmacokinetic-pharmacodynamic principles in rational and cost-effective drug development.
R. Lieberman, J. Mcmichael
1996Therapeutic Drug Monitoring23 citations
Semantic Scholar
Evolving strategies for prostate cancer chemoprevention trials
R. Lieberman
2003World journal of urology21 citations
Semantic Scholar
Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy.
J. Mcmichael, W. Irish, J. Mccauley, Richard A. Shapiro +6 more
1991Transplantation Proceedings21 citations
Semantic Scholar
Flutamide in Men with Prostatic Intraepithelial Neoplasia: A Randomized, Placebo-Controlled Chemoprevention Trial
S. Alberts, P. Novotny, J. Sloan, J. Danella +7 more
2006American Journal of Therapeutics20 citations
Semantic Scholar
A Pilot Surrogate End Point Biomarker Trial of Perillyl Alcohol in Breast Neoplasia
V. Stearns, A. Coop, Baljit Singh, A. Gallagher +6 more
2004Clinical Cancer Research19 citations Open access
Semantic Scholar
Preprostatectomy: A clinical model to study stromal-epithelial interactions.
W. Lopaczynski, A. Hruszkewycz, R. Lieberman
2001Urology19 citations
Semantic Scholar
An Intelligent and Cost‐Effective Computer Dosing System for Individualizing FK506 Therapy in Transplantation and Autoimmune Disorders
J. Mcmichael, R. Lieberman, H. Doyle, J. Mccauley +2 more
1993Journal of clinical pharmacology17 citations Open access
Semantic Scholar
Dose‐Response and Concentration—Response Relationships: Clinical and Regulatory Perspectives
R. Lieberman, R. Nelson
1993Therapeutic Drug Monitoring17 citations
Semantic Scholar
Computer-assisted image analysis-derived intermediate endpoints.
Charles W. Boone, R. Lieberman, Thomas Mairinger, Branko Palcic +2 more
2001Urology16 citations
Semantic Scholar
Bayesian monitoring of phase II trials in cancer chemoprevention.
K. Cronin, L. Freedman, R. Lieberman, H. Weiss +2 more
1999Journal of Clinical Epidemiology15 citations
Semantic Scholar
Cardiovascular safety monitoring during oncology drug development and therapy.
J. R. Turner, G. Panicker, D. Karnad, C. Cabell +2 more
2014American Journal of Therapeutics14 citations
Semantic Scholar
A Phase I Open Label Dose Escalation Study To Evaluate MEDI-507 in Patients with CD2-Positive T-Cell Lymphoma/Leukemia.
D. Casale, N. Bartlett, D. Hurd, F. Foss +4 more
200614 citations
Semantic Scholar
Immunopathologic changes in patients with cutaneous malignant melanoma following intratumoral inoculation of BCG: Correlation with cell‐mediated immunity
R. Lieberman, W. Epstein, H. Fudenberg
1974International Journal of Cancer13 citations
Semantic Scholar
An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer.
C. Waller, I. Vynnychenko, I. Bondarenko, Y. Shparyk +6 more
2015Clinical Lung Cancer12 citations
Semantic Scholar
Overview consensus statement.
P. Carroll, William R. Fair, G. Grossfeld, W. Heston +7 more
2001Urology12 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Kelloff×8
Invite
G. Kelloff — researcher profile on SciRah
J. Crowell×6
Invite
J. Crowell — researcher profile on SciRah
C. Sigman×5
Invite
C. Sigman — researcher profile on SciRah
Winfred A. Malone×4
Invite
Winfred A. Malone — researcher profile on SciRah

×4

Invite

C. Boone — researcher profile on SciRah

Invite

V. Steele — researcher profile on SciRah

Invite

R. Lubet — researcher profile on SciRah

L. Kopelovich×3

Invite

L. Kopelovich — researcher profile on SciRah

J. Mcmichael×3

Invite

J. Mcmichael — researcher profile on SciRah

Invite

E. Hawk — researcher profile on SciRah

Invite

J. Lawrence — researcher profile on SciRah

Invite

I. Ali — researcher profile on SciRah